Daniel K. Spiegelman - 10 Jun 2025 Form 4 Insider Report for vTv Therapeutics Inc. (VTVT)

Role: Director
Signature: /s/ Elizabeth Keiley, as Attorney-in-fact
Issuer symbol: VTVT
Transactions as of: 10 Jun 2025
Net transactions value: +$66,360
Form type: 4
Filing time: 12 Jun 2025, 16:28:17 UTC
Previous filing: 02 Jun 2025
Next filing: 24 Jul 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
SPIEGELMAN DANIEL K	Director	C/O VTV THERAPEUTICS INC., 3980 PREMIER DRIVE, SUITE 310, HIGH POINT	/s/ Elizabeth Keiley, as Attorney-in-fact	12 Jun 2025	0001238403

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VTVT	Director stock option (right to buy)	Award	$66,360	+4,000	+67%	$16.59	10,000	10 Jun 2025	Class A Common Stock	4,000	$16.59	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The option vests on the earlier of June 10, 2026, and the date of the 2026 annual general meeting of shareholders, subject to the director's continued service on the board of directors through such vesting.